Gram‑negative bacterial extracellular vesicles (bEVs), also known as outer‑membrane vesicles, have emerged as key mediators of intercellular signaling that can cross tissue barriers. This study investigates how bEVs released by the periodontopatho...
Gram‑negative bacterial extracellular vesicles (bEVs), also known as outer‑membrane vesicles, have emerged as key mediators of intercellular signaling that can cross tissue barriers. This study investigates how bEVs released by the periodontopathogen Aggregatibacter actinomycetemcomitans (Aa) influence both the oral–brain axis and head and neck squamous cell carcinoma (HNSCC). In a ligature‑induced mouse model of periodontitis, Aa‑derived bEVs administered by intragingival injection or bEV‑soaked hydrogel reached the brain and trigeminal ganglion (TG), where interleukin‑6 (IL‑6) and tumor necrosis factor‑α (TNF‑α) levels were significantly elevated. Human Embryonic Kidney (HEK) ‑Blue reporter assays and analyses in Myeloid differentiation primary response 88 (MyD88) ‑deficient mice showed that lipopolysaccharide (LPS) on the bEV surface activates Toll-like receptor 4 (TLR4), whereas RNA cargo within the bEV stimulates endosomal Toll-like receptor (TLR8), both converging on the MyD88–Nuclear factor kappa-light-chain-enhancer of activated B cells (NF‑κB) axis. Following trans‑epidermal or gingival administration, Aa‑derived bEVs were transported retrogradely along axons to TG neuronal somata, and electrophysiological recordings demonstrated reduced action‑potential thresholds and increased firing frequencies in small‑diameter nociceptive neurons, indicating enhanced neuroinflammatory sensitization. In parallel, two human HNSCC cell lines (UMSCC1 and FaDu) exposed to Aa‑derived bEVs exhibited accelerated cell‑cycle progression through the S and G2 phases, increased proliferative activity in Ki‑67 and Carboxyfluorescein succinimidyl ester (CFSE) assays, and enhanced invasiveness in Matrigel‑based invasion assays. Transcriptome profiling revealed broad reprogramming of gene expression, while microRNA (miRNA) sequencing identified selective upregulation of miR‑146a, a regulatory molecule linking immune modulation and tumorigenesis. Functionally, miR‑146a elevation correlated with increased invasion, highlighting a convergence between inflammatory and oncogenic pathways. Collectively, Aa‑derived bEVs exert distinct biological effects through two mechanistically linked routes: in neural tissues, they amplify IL‑6 and TNF‑α production via TLR4/8–MyD88–NF‑κB signaling and exRNA‑dependent activation, whereas in malignant epithelial cells, they remodel transcriptional and miRNA networks to promote proliferation and invasion. These findings position bEVs as pivotal molecular messengers that clarify how oral infection contributes to neuroinflammation and cancer progression and suggest clinical opportunities for targeting bEV biogenesis, circulation, cellular uptake, or TLR8‑dependent RNA signaling, as well as for developing bEV‑based liquid biopsy strategies.